Armed with FDA nod, Otsuka unit Astex preps to launch oral chemotherapy Inqovi

For nearly two decades, blood cancer patients have depended upon time-consuming infusions of the chemotherapy decitabine. Now, with an FDA approval for Astex Pharmaceuticals' oral version, they have an alternative.